A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients

Acta Oncologica

Volumn 49, Issue 4, 2010, Pages 500-505

  Isacsson, Ulf ^a   Nilsson, Kristina ^a   Asplund, Stefan ^a   Morhed, Elizabeth ^a   Montelius, Anders ^a   Turesson, Ingela ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(METHYL METHACRYLATE);

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; HUMAN; MALE; PHOTON THERAPY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROTON THERAPY; RADIATION DOSE FRACTIONATION; RECTUM; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; HUMANS; MALE; MIDDLE AGED; PHOTONS; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; SURGICAL INSTRUMENTS;

EID: 77951242177     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003745535     Document Type: Article

References (32)

1. Pisansky TM. External-beam radiotherapy for localized prostate cancer. N Engl J Med 2006;355:1583-1591
2. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-1105
3. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3-12.
4. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005;294:1233-1239
5. Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, et al. Phase II dose escalation study of imageguided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 2005;63:141-149
6. Vicini F, Vargas C, Edmundson G, Kestin L, Martinez A. The role of high-dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol 2003;13:98-108. (Pubitemid 36547487)
7. Mangar SA, Huddart RA, Parker CC, Dearnaley DP, Khoo VS, Horwich A. Technological advances in radiotherapy for the treatment of localised prostate cancer. Eur J Cancer 2005;41:908-921
8. Hara I, Murakami M, Kagawa K, Sugimura K, Kamidono S, Hishikawa Y, et al. Experience with conformal proton therapy for early prostate cancer. Am J Clin Oncol 2004;27:323-327
9. Mock U, Bogner J, Georg D, Auberger T, Potter R. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-455
10. Benk VA, Adams JA, Shipley WU, Urie MM, McManus PL, Efird JT, et al. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys 1993;26:551-557
11. Mechalakos JG, Mageras GS, Zelefsky MJ, Lyass O, van Herk M, Kooy HM, et al. Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy. Radiother Oncol 2002;62:261-265
12. Holupka EJ, Kaplan ID, Burdette EC, Svensson GK. Ultrasound image fusion for external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996;35: 975-984
13. Astrom L, Pedersen D, Mercke C, Holmang S, Johansson KA. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol 2005;74:157-161
14. Montelius A, Blomquist E, Naeser P, Brahme A, Carlsson J, Carlsson AC, et al. The narrow proton beam therapy unit at the Svedberg Laboratory in Uppsala. Acta Oncol 1991;30: 739-745
15. Grusell E, Montelius A, Russell KR, Blomquist E, Pellettieri L, Lilja A, et al. Patient positioning for fractionated precision radiation treatment of targets in the head using fiducial markers. Radiother Oncol 1994;33:68-72.
16. Dehnad H, Nederveen AJ, Van der Heide UA, Van Moorselaar RJA, Hofman P, Lagendijk JJW. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation, Radiother Oncol 2003;67:295-302
17. Jung B, Montelius A, Dahlin H, Ekströ m P, Ahnesj ö A, Högström B, et al. The conceptual design of a radiation oncology planning system. Comput Methods Programs Biomed 1997;52:79-92.
18. Montelius A, Jung B, Rikner G, Murman A, Russell K. Quality assurance tests of the TMS-radix treatment planning system. In: Breit A, editor. Advanced radiation therapy tumour response monitoring and treatment planning. Berlin, Heidelberg: Springer-Verlag; 1992. p. 523 -527
19. Russell KR, Isacsson U, Saxner M, Ahnesj ö A, Montelius A, Grusell E, et al. Implementation of pencil kernel and depth penetration algorithms for treatment planning of proton beams. Phys Med Biol 2000;45:9-27.
20. Ahnesjo A, Saxner M, Trepp A. A pencil beam model for photon dose calculation. Med Phys 1992;19:263-273
21. Dose formalism and models in helax-TMS. Helax AB. Uppsala, Sweden: 1998.
22. Fowler JF. Fractionated radiation therapy after Strandqvist. Acta Radiol Oncol 1984;23:209-216
23. Kupelian PA, Reddy CA, Klein EA, Willoughby TR. Shortcourse intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001;51:988-993
24. Brenner DJ. Hypofractionation for prostate cancer radiotherapy-what are the issues? Int J Radiat Oncol Biol Phys 2003;57:912-914
25. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999;43:1095-1101
26. Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6-13.
27. Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 2001;50:1021-1031
28. Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 2003;56:1093-1104
29. Logue JP, Cowan RA, Hendry JH. Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:1522-1523
30. Kupelian PA, Reddy CA, Carlson TP, Willoughby TR. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: Absolute or relative rectal volume? Cancer J 2002; 8:62-66
31. Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:1297-1308
32. Ishikawa H, Tsuji H, Kamada T, Yanagi T, Mizoe JE, Kanai T, et al. Carbon ion radiation therapy for prostate cancer: Results of a prospective phase II study. Radiother Oncol 2006;81:57-64.